Report highlights personalized medicines ensuring greater efficacy for rare diseases and previously untreatable conditions. Promising therapeutic developments for HIV, Parkinson’s disease, Crohn’s disease, alopecia, multiple myeloma and breast cancer on horizon
10 January, 2023